CANDICE DAVIS: Open Payments
NPI 1255055703 · WARRENTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$920 in 54 payments from 16 companies in 2025. Trend: 2023 $1,111 · 2024 $1,506 · 2025 $920
Food & beverage: $920
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $164 |
| Amgen Inc. | 10 | $149 |
| PFIZER INC. | 4 | $98 |
| Novo Nordisk Inc | 5 | $93 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $90 |
| Lilly USA, LLC | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Dexcom, Inc. | 1 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
Products named: CAPLYTA, Ozempic, VRAYLAR, OTEZLA, MOUNJARO, NURTEC ODT, Kerendia, UBRELVY.
Industry payments across VA — which companies pay providers there.
